Pillstats
Rx only · Tablet, Film Coated · Oral

Irbesartan And Hydrochlorothiazide

Brands: Avalide · Hydrochlorothiazide + Irbesartan

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)83818
US makers8 labelers
Packages44
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.56$5.12$7.69$10.25Oct 2025Mar 2026Jul 2026
$1.146
Latest avg · Jul 22, 2026
-87%
Since Oct 22, 2025
8
Active US suppliers
39%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.1K4.3K6.4K8.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
7.0K
Rx · 2026 Q1
393K
Units dispensed
-7%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Macleods Pharmaceuticals Limitedunknown10SUPPLYING
Bryant Ranch Prepackrepackager7SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown6SUPPLYING
Proficient Rx LPunknown6SUPPLYING
Aurobindo Pharma Limitedunknown5SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown4SUPPLYING
Alembic Pharmaceuticals Limitedunknown4SUPPLYING
Sanofi-Aventis U.S. LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 20, 2015
    RECALLRecall (Class III): Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: T…

    Labeling: Incorrect or Missing Lot AND/OR Exp Date. — Recalling firm: Teva Pharmaceutical Industries — Nationwide